154845-73-5Relevant articles and documents
Synthesis and anticonvulsant activity evaluation of 4-butyl-5-(4- alkoxyphenyl)-2H-1,2,4-triazole-3(4H)-ones
Zhu, Zi-Shi,Wang, Shi-Ben,Deng, Xian-Qing,Liu, Da-Chuan,Quan, Zhe-Shan
, p. 628 - 635 (2014/05/20)
A series of 4-butyl-5-(4-alkoxyphenyl)-2H-1,2,4-triazole-3(4H)-ones (6a-6u) was designed and synthesized. The anticonvulsant effects and neurotoxicity of the compounds were evaluated with maximal electroshock test and rotarod test. Among the synthetic compounds, 4-butyl-5-(4-(2-fluorinebenzyl)phenyl)-2H-1,2,4- triazole-3 (4H)-one (6k) was the most potent with ED50 value of 27.4 mg/kg and protective index (PI = TD50/ED50) value of 12.0. Besides the anti-MES efficacy, the potency of compound 6k against seizures induced by pentylenetetrazole (PTZ), 3-mercaptopropionic acid (3-MP), and bicuculline (BIC) was also established, which suggested that the mechanisms of action including enhancing of GABAergic activity might be involved in its anticonvulsant activity.
A new way to access chiral liquid crystals: Organocatalyst-mediated synthesis of chiral rod-like liquid crystals
Wang, Li,Liu, Xiao-Jun,Huang, Ping,Gong, Qing-Ping,Li, Yong-Hong,Wang, Bi-Qin,Zhao, Ke-Qing
scheme or table, p. 53 - 59 (2012/07/14)
In this article, an asymmetric organocatalytic way to prepare chiral liquid crystals from non-chiral starting materials was described. By using L-proline as the organocatalyst, several new chiral rod-like liquid crystals that are elusive with traditional methods were prepared. In addition, a series of novel enone-containing rod-like liquid crystals were also obtained as side-products. Mesomorphic properties of all new compounds were studied by Polarized Optical Microscope and Differential Scanning Calorimetry. Copyright Taylor & Francis Group, LLC.
Oxime Carbamate-Discovery of a series of novel FAAH inhibitors
Sit,Conway, Charles M.,Xie, Kai,Bertekap, Robert,Bourin, Clotilde,Burris, Kevin D.
supporting information; experimental part, p. 1272 - 1277 (2010/06/17)
A series of novel oxime carbamates have been identified as potent inhibitors of the key regulatory enzyme of the endocannabinoid signaling system, fatty acid amide hydrolase (FAAH). In this Letter, the rationale behind the discovery and the biological evaluations of this novel class of FAAH inhibitors are presented. Both in vitro and in vivo results of selected targets are discussed, along with inhibition kinetics and molecular modeling studies.1.